These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26282062)

  • 1. Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial.
    Umezawa Y; Nakagawa H; Tamaki K
    J Dermatol; 2016 Mar; 43(3):288-93. PubMed ID: 26282062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical combination therapy with vitamin D3 and corticosteroid ointment for palmoplantar pustulosis: A prospective, randomized, left-right comparison study.
    Muro M; Kawakami H; Matsumoto Y; Abe N; Tsuboi R; Okubo Y
    J Dermatolog Treat; 2016; 27(1):51-3. PubMed ID: 26108445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.
    Barker JN; Ashton RE; Marks R; Harris RI; Berth-Jones J
    Br J Dermatol; 1999 Aug; 141(2):274-8. PubMed ID: 10468799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
    Feldman SR; Matheson R; Bruce S; Grande K; Markowitz O; Kempers S; Brundage T; Wyres M;
    Am J Clin Dermatol; 2012 Aug; 13(4):261-71. PubMed ID: 22587791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
    Kragballe K; Steijlen PM; Ibsen HH; van de Kerkhof PC; Esmann J; Sorensen LH; Axelsen MB
    Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; al-Alem S; Abdulla SA
    Int J Tissue React; 2001; 23(2):59-62. PubMed ID: 11447774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study.
    Reich K; Graff O; Mehta N
    Br J Dermatol; 2016 Jun; 174(6):1277-81. PubMed ID: 26800106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
    Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial.
    Terui T; Kobayashi S; Okubo Y; Murakami M; Hirose K; Kubo H
    JAMA Dermatol; 2018 Mar; 154(3):309-316. PubMed ID: 29417135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.
    Pariser DM; Pariser RJ; Breneman D; Lebwohl M; Kalb R; Moore J; Moss H; Parker C; Fiedler V
    Arch Dermatol; 1996 Dec; 132(12):1527. PubMed ID: 8961897
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
    Feldman SR; Mills M; Brundage T; Eastman WJ
    J Drugs Dermatol; 2013 Mar; 12(3):300-6. PubMed ID: 23545912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of a supplementary cyclosporin administration with a topical application of maxacalcitol ointment for patients with moderate psoriasis vulgaris.
    Abe M; Syuto T; Hasegawa M; Yokoyama Y; Ishikawa O
    J Dermatol; 2009 Apr; 36(4):197-201. PubMed ID: 19348657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome: a multi-center, double-blind, randomized, placebo-controlled trial.
    Li N; Zhao W; Xing J; Liu J; Zhang G; Zhang Y; Li Y; Liu W; Shi F; Bai Y
    BMC Complement Altern Med; 2017 May; 17(1):264. PubMed ID: 28506228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH; Chiu HC; Tseng YS; Tsai TF
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
    Kircik L
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.